These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19416449)

  • 1. Chronic ingestion of Porphyromonas gingivalis induces systemic nitric oxide response in mice.
    Nemec A; Pavlica Z; Crossley DA; Sentjurc M; Jerin A; Erzen D; Vrecl M; Majdic G; Zdovc I; Petelin M; Skaleric U
    Oral Microbiol Immunol; 2009 Jun; 24(3):204-10. PubMed ID: 19416449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice.
    Nemec A; Pavlica Z; Petelin M; Crossley DA; Sentjurc M; Jerin A; Erzen D; Zdovc I; Hitti T; Skaleric U
    Arch Oral Biol; 2010 Jul; 55(7):509-14. PubMed ID: 20430367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single gavage with Porphyromonas gingivalis reduces acute systemic nitric oxide response in mice.
    Nemec A; Pavlica Z; Sentjurc M; Crossley DA; Jerin A; Erzen D; Zdovc I; Petelin M; Skaleric U
    Oral Microbiol Immunol; 2008 Oct; 23(5):435-9. PubMed ID: 18793369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.
    Thomsen LL; Scott JM; Topley P; Knowles RG; Keerie AJ; Frend AJ
    Cancer Res; 1997 Aug; 57(15):3300-4. PubMed ID: 9242464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
    Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
    J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-specific modulation of the nitric oxide pathway after acute experimentally induced endotoxemia.
    Bachetti T; Pasini E; Suzuki H; Ferrari R
    Crit Care Med; 2003 May; 31(5):1509-14. PubMed ID: 12771626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide and nuclear factor-kappaB in the CYP2E1 potentiation of tumor necrosis factor alpha hepatotoxicity in mice.
    Wu D; Xu C; Cederbaum A
    Free Radic Biol Med; 2009 Feb; 46(4):480-91. PubMed ID: 19063961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
    Slomiany BL; Slomiany A
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):85-98. PubMed ID: 15082869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early systemic inflammatory response in mice after a single oral gavage with live Escherichia coli is evidenced by increased TNF-alpha and nitric oxide production.
    Nemec A; Jerin A; Zdovc I; Budefeld T; Verstraete FJ; Eržen D; Sentjurc M; Petelin M; Hitti T; Pavlica Z
    Res Vet Sci; 2012 Jun; 92(3):401-7. PubMed ID: 21489584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid A-associated proteins from Porphyromonas gingivalis stimulate release of nitric oxide by inducing expression of inducible nitric oxide synthase.
    Choi EY; Hwang YM; Lee JY; Choi JI; Choi IS; Jin JY; Ko JS; Kim SJ
    J Periodontal Res; 2007 Aug; 42(4):350-60. PubMed ID: 17559633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1400W blocks death pathway of LPS-induced activated-microglia to preOLs].
    He YF; Chen HJ; Qian LH; Chen GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):357-62. PubMed ID: 20497644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyromonas gingivalis stimulates the release of nitric oxide by inducing expression of inducible nitric oxide synthases and inhibiting endothelial nitric oxide synthases.
    Sun W; Wu J; Lin L; Huang Y; Chen Q; Ji Y
    J Periodontal Res; 2010 Jun; 45(3):381-8. PubMed ID: 20337893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inducible nitric oxide synthase expressed by alveolar macrophages in high mobility group box 1--induced acute lung injury.
    Ren D; Sun R; Wang S
    Inflamm Res; 2006 May; 55(5):207-15. PubMed ID: 16830108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.
    Mark LA; Robinson AV; Schulak JA
    J Surg Res; 2005 Dec; 129(2):236-41. PubMed ID: 16140334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage.
    Alayan J; Ivanovski S; Gemmell E; Ford P; Hamlet S; Farah CS
    Oral Microbiol Immunol; 2006 Dec; 21(6):360-5. PubMed ID: 17064393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclosporin A on the expression of inducible nitric oxide synthase in the gingiva of rats.
    Gau CH; Chou TC; Chiu HC; Shen EC; Nieh S; Chiang CY; Fu E
    J Periodontol; 2005 Dec; 76(12):2260-6. PubMed ID: 16332238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
    Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NO2-/NO3- levels in blood and principal organs in rats treated with lipopolysaccharide].
    Sakemi K; Ohno Y; Tsuda M
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):101-6. PubMed ID: 10097517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide protection against adriamycin-induced tubulointerstitial injury.
    Oteki T; Nagase S; Shimohata H; Hirayama A; Ueda A; Yokoyama H; Yoshimura T
    Free Radic Res; 2008 Feb; 42(2):154-61. PubMed ID: 18297608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of FR260330, a novel orally active inducible nitric oxide synthase inhibitor.
    Chida N; Hirasawa Y; Ohkawa T; Ishii Y; Sudo Y; Tamura K; Mutoh S
    Eur J Pharmacol; 2005 Feb; 509(1):71-6. PubMed ID: 15713431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.